Drugs available on Contract - [XOLAIR 150MG INJ (NVS/COL) OMALIZUMAB], []
|
|
40
|
|
|
B4911
|
|
|
XOLAIR 150MG INJ (NVS/COL) OMALIZUMAB
|
|
|
OMALIZUMAB
|
|
|
XOLAIR
|
|
|
150MG VIAL
|
|
|
C
|
|
|
1,304.93
|
|
|
1,304.93
|
|
|
150MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
4810
|
|
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
RESPIRATORY TRACT AGENTS
|
|
|
|